Pyrazole, an alcohol dehydrogenase inhibitor, has dual effects on N-methyl-D-aspartate receptors of hippocampal pyramidal cells: agonist and noncompetitive antagonist.

doi:10.1016/s0022-3565(25)10980-4

Paper

Pyrazole, an alcohol dehydrogenase inhibitor, has dual effects on N-methyl-D-aspartate receptors of hippocampal pyramidal cells: agonist and noncompetitive antagonist.

Published Apr 1, 1992 · E. Pereira, Y. Aracava, R. Aronstam

The Journal of pharmacology and experimental therapeutics

Q2 SJR score

19

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Pyrazole, a potential therapeutic agent for treating alcoholic intoxication, has dual effects on NMDA receptors, acting as both an agonist and noncompetitive antagonist, potentially improving our understanding of this receptor.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Pyrazole, an alcohol dehydrogenase inhibitor, has dual effects on N-methyl-D-aspartate receptors of hippocampal pyramidal cells: agonist and noncompetitive antagonist.

References

Citations